Literature DB >> 32813036

Opinion leaders in the medical community attract more attention than randomized controlled trials in shoulder surgery.

Carlos Torrens1, Fernando Santana2, Joan Miquel3.   

Abstract

PURPOSE: The objective of this study was to determine whether opinion leaders in the medical community attract more attention than randomized controlled trials (RCT) in shoulder surgery.
METHODS: A PubMed search to retrieve all therapeutic and diagnosis RCT shoulder studies was carried out. Three opinion leaders were chosen from among the last ten presidents of the European Shoulder and Elbow Society based on the number of publications. Their studies were also retrieved from PubMed. The metrics of the studies were determined through ResearchGate and Web of Science. The year of publication, impact factor of the journal, level of evidence, number of citations, number of reads, research interest, and reported conflicts of interest were recorded for every study.
RESULTS: Two-hundred forty-five shoulder RCTs and 236 opinion leader studies met the inclusion criteria. The opinion leader studies were read significantly more times than the RCTs (p = 0.04). The mean impact factor for RCT studies was 2.84 (SD 3.9) while it was of 1.99 (SD1.14) in the opinion leader group (p < 0.001). Most of the studies of the opinion leaders were level IV (73.3%), while only 6.3% of their papers were categorized as levels I-II. Conflict of interest was present in 19.6% of the RCTs and in 32.2% of the opinion leader studies (p < 0.001).
CONCLUSION: The medical community pays more attention to opinion leader studies in shoulder surgery than to RCT studies even though RCTs are published in higher impact factor journals and opinion leader studies are mainly level IV evidence studies.

Keywords:  Citations; Conflicts of interest; Impact factor; Opinion leaders; Randomized control trials

Year:  2020        PMID: 32813036     DOI: 10.1007/s00264-020-04775-8

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  7 in total

Review 1.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

2.  Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

Authors:  Bodil Als-Nielsen; Wendong Chen; Christian Gluud; Lise L Kjaergard
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

3.  Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.

Authors:  Mohit Bhandari; Jason W Busse; Dianne Jackowski; Victor M Montori; Holger Schünemann; Sheila Sprague; Derek Mears; Emil H Schemitsch; Dianne Heels-Ansdell; P J Devereaux
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

4.  From disclosure to transparency: the use of company payment data.

Authors:  Susan Chimonas; Zachary Frosch; David J Rothman
Journal:  Arch Intern Med       Date:  2010-09-13

5.  Orthopaedic surgeons and the medical device industry: the threat to scientific integrity and the public trust.

Authors:  Richard H Gelberman; David Samson; Sohail K Mirza; John J Callaghan; Vincent D Pellegrini
Journal:  J Bone Joint Surg Am       Date:  2010-03       Impact factor: 5.284

Review 6.  Does source of funding and conflict of interest influence the outcome and quality of spinal research?

Authors:  Amir Reza Amiri; Kavitha Kanesalingam; Suzie Cro; Adrian T H Casey
Journal:  Spine J       Date:  2013-11-12       Impact factor: 4.166

7.  Impact of the PROFHER trial findings on surgeons' clinical practice: An online questionnaire survey.

Authors:  L Jefferson; S Brealey; H Handoll; A Keding; L Kottam; I Sbizzera; A Rangan
Journal:  Bone Joint Res       Date:  2017-10       Impact factor: 5.853

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.